HHS cancels Moderna mRNA vaccine award amid safety concerns
HEAVILY 30% 80% Wednesday, May 28, 2025, 9:22 pm
The Department of Health and Human Services abruptly cancelled funding for Moderna’s mRNA-based bird flu vaccine, citing safety concerns and insufficient testing. This sudden decision highlights the administration’s cautious stance on rapidly developed mRNA technology, leaving industry observers both baffled and amused.
Bluesky: @isaidhi.bsky.social, @cbsnews.com.web.brid.gy
Trump HHS ends nearly $1 billion in funding to Moderna for mRNA bird flu vaccines, citing safety concerns and lack of oversight around the new mRNA vaccine technology.
The Trump administration canceled a nearly $600 million award to Moderna to develop an mRNA vaccine for bird flu in humans, the company announced Wednesday.Why it matters: It ends one of the remaining Biden-era efforts aimed at creating vaccines for pandemic preparedness. But the company said it…
The Trump administration has canceled $766 million awarded to Moderna to develop a vaccine against potential pandemic influenza viruses, including the H5N1 bird flu.
The cancelation came as Moderna announced positive interim results from an early-stage trial of a new shot.
permalink / 4 stories from sources in 4 days ago #healthcare #safety #covid #moderna
More Top Stories...
Senate split deepens over contentious healthcare megabill debate
Lawmakers are locked in a high-stakes standoff over the new healthcare megabill. As Medicaid moderates hold crucial sway and Republican senators cast doubts, partisan divisions intensify. This legislative tug-of-war could reshape national healthcare policies, leaving critics shaking their heads at the chaos. More...
Controversial One Big Beautiful Bill Ignites Fiscal Outrage and Debate
The flagship tax-and-spending proposal backed by President Trump has come under fire after revelations of a contentious paragraph that could hike deficits by $2.3 trillion over a decade. Critics and fiscal watchdogs are questioning the bill’s hidden costs as GOP allies launch a high-stakes lobbying effort to shore up support. More...
Trump’s Tariff Strategy Faces Unprecedented Legal Scrutiny
President Trump’s aggressive tariff policy is now under judicial fire as conservative legal scholars and critics from across the aisle decry the president’s unilateral moves. Courts have begun challenging the statutory basis for these steep import duties, forcing a constitutional debate that underscores the limits of executive power. More...
Trump-Backed Polish Presidential Victory Seals a New Chapter
In Poland’s heated election runoff, conservative candidate Karol Nawrocki—backed by Trump—narrowly clinched the presidency, marking a pivotal political shift. Observers note the unexpected yet definitive win that reshapes the nation’s political landscape, proving electoral surprises are never dull. More...
US Visa Revocation Plan Sparks Political Backlash
The administration’s move to revoke visas for Chinese students has ignited intense political criticism. Analysis of the policy’s potential fallout was matched by a sharp rebuke from a prominent lawmaker, who deemed the plan “terribly misguided.” The controversy underscores rising tensions over academic freedom and international relations. More...
Related Tags
Healthcare
Senate split deepens over contentious healthcare megabill debate (3 hours ago)
FDA chief outlines COVID vaccine guidance amid controversy (17 hours ago)
Devin Harjes dies at 41 from cancer complications (18 hours ago)
Safety
Mount Etna Erupts, Disrupting Local Tourist Safety (1 hour ago)
Stabbing at Salem Oregon Homeless Mission Shakes Community (6 hours ago)
Missouri House Explosion Shocks Local Community (13 hours ago)
COVID
FDA chief outlines COVID vaccine guidance amid controversy (17 hours ago)
Moderna’s Next-Gen Shot Approved (45 hours ago)
CDC Revises Child COVID-19 Vaccination Guidance Amid Debate (2 days ago)
Moderna
Moderna’s Next-Gen Shot Approved (45 hours ago)
CDC Revises Child COVID-19 Vaccination Guidance Amid Debate (2 days ago)
Trump Administration Axes Moderna’s Bird Flu Vaccine Contract (3 days ago)